Merck Sharp & Dohme lodges cross appeal in Prevnar 13 vaccine patent spat

Intellectual Property 2021-01-25 4:33 pm By Miklos Bolza | Melbourne

Drug giant Merck Sharp & Dohme has brought a cross appeal in its long-running intellectual property dispute with Pfizer’s Wyeth over the top selling Prevnar 13 pneumococcal vaccine.